The latest trading session saw Organon (OGN) ending at $21.86, denoting a -1.84% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 1.08% for the day. Elsewhere, the Dow saw an upswing of 0.75%, while the tech-heavy Nasdaq appreciated by 2.64%.Shares of the pharmaceutical company witnessed a gain of 10.69% over the previous month, beating the performance of the Medical sector with its gain of 0.71% and the S&P 500's loss of 0.44%.Analysts and investors alik ...

Organon (OGN) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on August 6. On the o ...

Lucy Lambriex/DigitalVision via Getty Images Investment Overview I last covered Organon (NYSE:OGN), a company whose stock I own, back in mid-February, reviewing a positive set of full-year 2023 earnings that sent shares rising in value from ~$16, to ~$19, adding fresh momentum to a bull run that began in December 2023. Until late-December, Organon stock had experienced a torrid 2023, sinking in value from $32 per share in January, to ~$11.5 at the end of November, for an overall loss of nearly 65%. The ...

Organon (OGN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power of ...

Organon (OGN) closed at $20.81 in the latest trading session, marking a +0.39% move from the prior day. This change lagged the S&P 500's 0.64% gain on the day. At the same time, the Dow added 1.85%, and the tech-heavy Nasdaq gained 0.2%.The pharmaceutical company's shares have seen an increase of 1.87% over the last month, surpassing the Medical sector's gain of 0.71% and falling behind the S&P 500's gain of 3.82%.Market participants will be closely following the financial results of Organon in its upcoming ...

Organon (OGN) ended the recent trading session at $19.93, demonstrating a -1.04% swing from the preceding day's closing price. This change lagged the S&P 500's 0.07% gain on the day. Elsewhere, the Dow lost 0.13%, while the tech-heavy Nasdaq added 0.14%.The pharmaceutical company's shares have seen a decrease of 2.75% over the last month, not keeping up with the Medical sector's loss of 1.99% and the S&P 500's gain of 4.34%.The investment community will be closely monitoring the performance of Organon in it ...

In the latest market close, Organon (OGN) reached $20.63, with a -0.77% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.16%. On the other hand, the Dow registered a gain of 0.04%, and the technology-centric Nasdaq increased by 0.49%. Prior to today's trading, shares of the pharmaceutical company had lost 0.91% over the past month. This has lagged the Medical sector's gain of 2.32% and the S&P 500's gain of 3.22% in that time. The upcoming earnings rel ...

Organon (OGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Shares of this pharmaceutical company have returned -0.9% over the past month versus the Zacks S&P 500 composite's +3.2% change. The Zacks Medical Services industry, to which Organon belongs, has gained 0.5% over this period. Now the key question is: Where could the stock be headed in the near term? Alt ...

The latest trading session saw Organon (OGN) ending at $20.45, denoting a +0.49% adjustment from its last day's close. The stock outpaced the S&P 500's daily loss of 0.25%. Meanwhile, the Dow experienced a rise of 0.77%, and the technology-dominated Nasdaq saw a decrease of 0.79%. The pharmaceutical company's shares have seen a decrease of 7.33% over the last month, not keeping up with the Medical sector's gain of 0.03% and the S&P 500's gain of 3.59%. The investment community will be paying close attention ...

Organon (OGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the past month, shares of this pharmaceutical company have returned -5.1%, compared to the Zacks S&P 500 composite's +3.1% change. During this period, the Zacks Medical Services industry, which Organon falls in, has gained 0.9%. The key question now is: What could be the stock's future direction? Although media ...